A phase I/II study of fosbretabulin in combination with everolimus in neuroendocrine tumors that have progressed after at least one prior regimen for metastatic disease.
Year: 2018
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Aman Chauhan, Susanne Arnold, Stacey A. Slone, Heather Flynn, Heidi Weiss, Lowell Brian Anthony
Institutions: University of Kentucky, Markey Cancer Center
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2890170672